U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 1,455 records

Showing results for "analyzing".

  1. Symposium on Methods for Developing and Analyzing Clinically Rich Data for Patient-Centered Outcomes Research - Part III | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/patient-outcomes-symposium/overview
    November 01, 2018 - Home Evidence Reports Symposium on Methods for Developing and Analyzing … SHARE: Symposium on Methods for Developing and Analyzing … Methods for Developing and Analyzing Clinically Rich Data for Patient-Centered Outcomes Research: An … Concato Analyzing Partially Missing Confounder Information in Comparative Effectiveness and Safety … Griffin Project Timeline Symposium on Methods for Developing and Analyzing

  2. Executive Summary_Systematic Review: Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-executive-summary.pdf
    March 01, 2025 - Analyzing carbohydrate intake as a percentage of total energy intake showed a gradual decrease in the … Similarly, analyzing carbohydrate intake in grams per day revealed a steady decline in CVD risk up to … Analyzing carbohydrate intake as a percentage of total energy intake showed a relatively flat risk of … Similarly, analyzing carbohydrate intake in grams per day revealed a 5 flat CHD … Similarly, analyzing carbohydrate intake in grams per day showed a reduced risk up to 260 grams per

  3. Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/effect-dietary-digestible/research
    March 01, 2025 - Analyzing carbohydrate intake as a percentage of total energy intake showed a gradual reduction in the … Similarly, analyzing carbohydrate intake in grams per day revealed a gradually reduced risk up to 270

  4. Chapter 8: Meta-Analysis of Test Performance When There Is a “Gold Standard” | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/methods-guidance-tests-metaanalysis/methods
    December 01, 2019 - We briefly outline common approaches for meta-analyzing medical tests, and discuss principles for choosing … Why could directly meta-analyzing likelihood ratios be problematic? … and specificity rarely results in different conclusions. 24 What should be said about directly meta-analyzing … Characteristics of Meta-Analysis Methods Over several decades many methods have been used for meta-analyzing … negative likelihood ratios from summary estimates of sensitivity and specificity, rather than meta-analyzing

  5. Methods Guide for Medical Test Reviews (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-metaanalysis_methods.pdf
    July 01, 2012 - We briefly outline common approaches for meta- analyzing medical tests, and discuss principles for choosing … Why could directly meta-analyzing likelihood ratios be problematic? … and specificity rarely results in different conclusions.24 What should be said about directly meta-analyzing … Characteristics of Meta-Analysis Methods Over several decades many methods have been used for meta-analyzing … negative likelihood ratios from summary estimates of sensitivity and specificity, rather than meta-analyzing

  6. Effective Health Care (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0095_04-10-2009.pdf
    January 01, 2009 - In addition to analyzing the existing research, the final report will focus on defining the evidence

  7. Community Pharmacy/Call Center Assessment of Medication Effectiveness & Safety | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/medicine-safety-call-center/research
    November 01, 2017 - development of a web based drug effectiveness reporting and monitoring system that builds on previous studies analyzing

  8. Cannabis-2022-Update-Surv-Rep-1-App-F1-4 (xls file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
    January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

  9. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 0 (xls file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
    February 16, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

  10. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
    January 01, 2022 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

  11. Appendix-E-Evidence-Tables-E1-E4 0 (xls file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
    November 04, 2021 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

  12. App-E-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

  13. Cannabis-2023-Surv-Rep-1-App-F (xls file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  14. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  15. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  16. Cannabis-2022-Surv-Rep-3-Tables-F1-4 (xls file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  17. App-E-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

  18. Cer-250-Cannabis-2024-Surv-Rep-Update-Tables-E1-4 (xls file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
    January 01, 2024 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  19. Health Occupations | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/health-topics/health-occupations?page=1
    March 26, 2013 - Effectiveness Reviews Overview May 3, 2012 Symposium on Methods for Developing and Analyzing

  20. App-E-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites